Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17,345 persons.
<h4>Background</h4>Early identification of ambulatory persons at high short-term risk of death could benefit targeted prevention. To identify biomarkers for all-cause mortality and enhance risk prediction, we conducted high-throughput profiling of blood specimens in two large population-...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2014
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/6a872e0ae49e4ad9a2500c9c8ff199a1 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:6a872e0ae49e4ad9a2500c9c8ff199a1 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:6a872e0ae49e4ad9a2500c9c8ff199a12021-11-18T05:42:57ZBiomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17,345 persons.1549-12771549-167610.1371/journal.pmed.1001606https://doaj.org/article/6a872e0ae49e4ad9a2500c9c8ff199a12014-02-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24586121/?tool=EBIhttps://doaj.org/toc/1549-1277https://doaj.org/toc/1549-1676<h4>Background</h4>Early identification of ambulatory persons at high short-term risk of death could benefit targeted prevention. To identify biomarkers for all-cause mortality and enhance risk prediction, we conducted high-throughput profiling of blood specimens in two large population-based cohorts.<h4>Methods and findings</h4>106 candidate biomarkers were quantified by nuclear magnetic resonance spectroscopy of non-fasting plasma samples from a random subset of the Estonian Biobank (n = 9,842; age range 18-103 y; 508 deaths during a median of 5.4 y of follow-up). Biomarkers for all-cause mortality were examined using stepwise proportional hazards models. Significant biomarkers were validated and incremental predictive utility assessed in a population-based cohort from Finland (n = 7,503; 176 deaths during 5 y of follow-up). Four circulating biomarkers predicted the risk of all-cause mortality among participants from the Estonian Biobank after adjusting for conventional risk factors: alpha-1-acid glycoprotein (hazard ratio [HR] 1.67 per 1-standard deviation increment, 95% CI 1.53-1.82, p = 5×10⁻³¹), albumin (HR 0.70, 95% CI 0.65-0.76, p = 2×10⁻¹⁸), very-low-density lipoprotein particle size (HR 0.69, 95% CI 0.62-0.77, p = 3×10⁻¹²), and citrate (HR 1.33, 95% CI 1.21-1.45, p = 5×10⁻¹⁰). All four biomarkers were predictive of cardiovascular mortality, as well as death from cancer and other nonvascular diseases. One in five participants in the Estonian Biobank cohort with a biomarker summary score within the highest percentile died during the first year of follow-up, indicating prominent systemic reflections of frailty. The biomarker associations all replicated in the Finnish validation cohort. Including the four biomarkers in a risk prediction score improved risk assessment for 5-y mortality (increase in C-statistics 0.031, p = 0.01; continuous reclassification improvement 26.3%, p = 0.001).<h4>Conclusions</h4>Biomarker associations with cardiovascular, nonvascular, and cancer mortality suggest novel systemic connectivities across seemingly disparate morbidities. The biomarker profiling improved prediction of the short-term risk of death from all causes above established risk factors. Further investigations are needed to clarify the biological mechanisms and the utility of these biomarkers for guiding screening and prevention.Krista FischerJohannes KettunenPeter WürtzToomas HallerAki S HavulinnaAntti J KangasPasi SoininenTõnu EskoMari-Liis TammesooReedik MägiSteven SmitAarno PalotieSamuli RipattiVeikko SalomaaMika Ala-KorpelaMarkus PerolaAndres MetspaluPublic Library of Science (PLoS)articleMedicineRENPLoS Medicine, Vol 11, Iss 2, p e1001606 (2014) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R |
| spellingShingle |
Medicine R Krista Fischer Johannes Kettunen Peter Würtz Toomas Haller Aki S Havulinna Antti J Kangas Pasi Soininen Tõnu Esko Mari-Liis Tammesoo Reedik Mägi Steven Smit Aarno Palotie Samuli Ripatti Veikko Salomaa Mika Ala-Korpela Markus Perola Andres Metspalu Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17,345 persons. |
| description |
<h4>Background</h4>Early identification of ambulatory persons at high short-term risk of death could benefit targeted prevention. To identify biomarkers for all-cause mortality and enhance risk prediction, we conducted high-throughput profiling of blood specimens in two large population-based cohorts.<h4>Methods and findings</h4>106 candidate biomarkers were quantified by nuclear magnetic resonance spectroscopy of non-fasting plasma samples from a random subset of the Estonian Biobank (n = 9,842; age range 18-103 y; 508 deaths during a median of 5.4 y of follow-up). Biomarkers for all-cause mortality were examined using stepwise proportional hazards models. Significant biomarkers were validated and incremental predictive utility assessed in a population-based cohort from Finland (n = 7,503; 176 deaths during 5 y of follow-up). Four circulating biomarkers predicted the risk of all-cause mortality among participants from the Estonian Biobank after adjusting for conventional risk factors: alpha-1-acid glycoprotein (hazard ratio [HR] 1.67 per 1-standard deviation increment, 95% CI 1.53-1.82, p = 5×10⁻³¹), albumin (HR 0.70, 95% CI 0.65-0.76, p = 2×10⁻¹⁸), very-low-density lipoprotein particle size (HR 0.69, 95% CI 0.62-0.77, p = 3×10⁻¹²), and citrate (HR 1.33, 95% CI 1.21-1.45, p = 5×10⁻¹⁰). All four biomarkers were predictive of cardiovascular mortality, as well as death from cancer and other nonvascular diseases. One in five participants in the Estonian Biobank cohort with a biomarker summary score within the highest percentile died during the first year of follow-up, indicating prominent systemic reflections of frailty. The biomarker associations all replicated in the Finnish validation cohort. Including the four biomarkers in a risk prediction score improved risk assessment for 5-y mortality (increase in C-statistics 0.031, p = 0.01; continuous reclassification improvement 26.3%, p = 0.001).<h4>Conclusions</h4>Biomarker associations with cardiovascular, nonvascular, and cancer mortality suggest novel systemic connectivities across seemingly disparate morbidities. The biomarker profiling improved prediction of the short-term risk of death from all causes above established risk factors. Further investigations are needed to clarify the biological mechanisms and the utility of these biomarkers for guiding screening and prevention. |
| format |
article |
| author |
Krista Fischer Johannes Kettunen Peter Würtz Toomas Haller Aki S Havulinna Antti J Kangas Pasi Soininen Tõnu Esko Mari-Liis Tammesoo Reedik Mägi Steven Smit Aarno Palotie Samuli Ripatti Veikko Salomaa Mika Ala-Korpela Markus Perola Andres Metspalu |
| author_facet |
Krista Fischer Johannes Kettunen Peter Würtz Toomas Haller Aki S Havulinna Antti J Kangas Pasi Soininen Tõnu Esko Mari-Liis Tammesoo Reedik Mägi Steven Smit Aarno Palotie Samuli Ripatti Veikko Salomaa Mika Ala-Korpela Markus Perola Andres Metspalu |
| author_sort |
Krista Fischer |
| title |
Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17,345 persons. |
| title_short |
Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17,345 persons. |
| title_full |
Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17,345 persons. |
| title_fullStr |
Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17,345 persons. |
| title_full_unstemmed |
Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17,345 persons. |
| title_sort |
biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17,345 persons. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2014 |
| url |
https://doaj.org/article/6a872e0ae49e4ad9a2500c9c8ff199a1 |
| work_keys_str_mv |
AT kristafischer biomarkerprofilingbynuclearmagneticresonancespectroscopyforthepredictionofallcausemortalityanobservationalstudyof17345persons AT johanneskettunen biomarkerprofilingbynuclearmagneticresonancespectroscopyforthepredictionofallcausemortalityanobservationalstudyof17345persons AT peterwurtz biomarkerprofilingbynuclearmagneticresonancespectroscopyforthepredictionofallcausemortalityanobservationalstudyof17345persons AT toomashaller biomarkerprofilingbynuclearmagneticresonancespectroscopyforthepredictionofallcausemortalityanobservationalstudyof17345persons AT akishavulinna biomarkerprofilingbynuclearmagneticresonancespectroscopyforthepredictionofallcausemortalityanobservationalstudyof17345persons AT anttijkangas biomarkerprofilingbynuclearmagneticresonancespectroscopyforthepredictionofallcausemortalityanobservationalstudyof17345persons AT pasisoininen biomarkerprofilingbynuclearmagneticresonancespectroscopyforthepredictionofallcausemortalityanobservationalstudyof17345persons AT tonuesko biomarkerprofilingbynuclearmagneticresonancespectroscopyforthepredictionofallcausemortalityanobservationalstudyof17345persons AT mariliistammesoo biomarkerprofilingbynuclearmagneticresonancespectroscopyforthepredictionofallcausemortalityanobservationalstudyof17345persons AT reedikmagi biomarkerprofilingbynuclearmagneticresonancespectroscopyforthepredictionofallcausemortalityanobservationalstudyof17345persons AT stevensmit biomarkerprofilingbynuclearmagneticresonancespectroscopyforthepredictionofallcausemortalityanobservationalstudyof17345persons AT aarnopalotie biomarkerprofilingbynuclearmagneticresonancespectroscopyforthepredictionofallcausemortalityanobservationalstudyof17345persons AT samuliripatti biomarkerprofilingbynuclearmagneticresonancespectroscopyforthepredictionofallcausemortalityanobservationalstudyof17345persons AT veikkosalomaa biomarkerprofilingbynuclearmagneticresonancespectroscopyforthepredictionofallcausemortalityanobservationalstudyof17345persons AT mikaalakorpela biomarkerprofilingbynuclearmagneticresonancespectroscopyforthepredictionofallcausemortalityanobservationalstudyof17345persons AT markusperola biomarkerprofilingbynuclearmagneticresonancespectroscopyforthepredictionofallcausemortalityanobservationalstudyof17345persons AT andresmetspalu biomarkerprofilingbynuclearmagneticresonancespectroscopyforthepredictionofallcausemortalityanobservationalstudyof17345persons |
| _version_ |
1718424790525542400 |